Ophthalamin – bioregulator of the organ of vision
Ophthalamin is produced from the cattle and pig ophthalmic tissues. It
is a nucleoprotein complex, which acts selectively on ophthalmic tissue cells
promoting the recovery of visual function.
Clinical trials were conducted on 194 patients with retinal dystrophy of
various etiology and posttraumatic endothelial epithelial dystrophy of the
retina. Control groups consisted of 135 similar patients who underwent standard
treatment.
Ophthalamin effectiveness was estimated subjectively and with respect to
objective indices. All patients were examined prior to and after treatment
according to complex clinical programme , including alongside indispensable
standard methods, precise diagnosis of visual functions disturbances, rate of
blood flow, the state of external and internal layers of the retina, the state
of pigmentary epithelium of the retina.
Standard method of examination included: visual acuity and fields of
vision tests, darkness adaptation analysis, intracranial pressure measurement,
biomicroscopy of anterior section of the eye and deep optic media,
biomicroophthalmoscopy, stereoophthalmoscopy, direct ophthalmoscopy.
Methods of examination included: visocontrastometry, static and multiple
perimetry, color perception study, fluorescent angiography of the fundus of the
eye, dopplerography and electrophysiological examination.
There were conducted clinical blood and urine tests, blood biochemistry.
Estimation of clinical and laboratory functional parameters showed
alterations in all departments of the eye (iris, lens, vitreous body, optic
nerve) in patients with retinal dystrophies, which suggested generalization of
pathological process with the tendency of progressing with the development of
the disease.
As a result of clinical trials, it was established that ophthalamin
application gave maximum therapeutic effect in patients with initial forms of
retinal degeneration. It was obvious due to vision acuity increase and visual
fields expansion (widening of peripheral borders, reduction or disappearance of
paracentral scotomas).
Ophthalamin application for patients with posttraumatic visual
disturbances promoted 1.3 - 1.4-fold the recovery of epithelial layer
completeness and visual acuity.
Incomplicated course of residual period brought to complete recovery and
disappearance of signs of blepharospasm, photophobia and final formation of the
corneal cicatrix.
Ophthalamin treatment of patients with partial destruction of the cornea
in postoperative period helped to escape infectious complications and
facilitated corneal transplantation.
Chemical structure
and nutritional value of Ophthalamin:
|
Nutritional substances,
% |
Vitamins, mg/10
mg |
||
|
Protein |
56,7 |
Thiamin(B1) |
0,09 |
|
Fats |
9,8 |
Riboflavin(B2) |
0,012 |
|
Carbohydrates |
<0,01 |
Niacin(PP) |
0 |
|
Ashes |
2,2 |
Retinol(A) |
0,17 |
|
|
à-Tocopherol(E) |
0,42 |
|
|
Mineral substances, mg/10mg |
Aminoacids, nmol/mg |
||
|
Aluminium |
0,1572 |
Asparagine |
508 |
|
Cobalt |
0 |
Threonine |
178 |
|
Copper |
0,0989 |
Serine |
338 |
|
Iron |
4,26 |
Glutamine |
658 |
|
Magnesium |
1,66 |
Proline |
365 |
|
Calcium |
29,15 |
Glycine |
390 |
|
Potassium |
37,83 |
Alanine |
293 |
|
Sodium |
422,31 |
Valine |
300 |
|
Manganese |
0,0244 |
Methionine |
0 |
|
Molybdenum |
0 |
Isoleucine |
203 |
|
Phosphorus |
58,45 |
Leucine |
385 |
|
Sulfur |
126,2 |
Tyrosine |
168 |
|
Zinc |
12,5 |
Phenylalanine |
203 |
|
Lead |
0 |
Histidine |
185 |
|
Cadmium |
0 |
Lysine |
273 |
|
|
Arginine |
290 |
|
Ophthalamin is recommended for accelerated recovery of ophthalmic tissue
functions in case of various lesions of the latter, including retinal
degeneration and posttraumatic corneal dystrophy. It is also recommended to the
elderly for maintaining visual functions.
No side effects have been registered.
It should be stored in a dry cool light protected place.
Dr. Giorgio Castello
Via A. Cecchi, 19/9
16129 – Genova (Italy)
Phone:
Mobil
phone :
e-mail:
castello@tiopoietine.info